Daniel Hargbøl Madsen

Daniel Hargbøl Madsen

Associate Professor


Publication year:
All
1 - 2 out of 2Page size: 10
  1. 2023
  2. Published

    Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma

    Frias, A., Di Leo, L., Antoranz, A., Nazerai, L., Carretta, M., Bodemeyer, V., Pagliuca, C., Dahl, C., Claps, G., Mandelli, G. E., Andhari, M. D., Pacheco, M. P., Sauter, T., Robert, C., Guldberg, P., Madsen, Daniel Hargbøl, Cecconi, F., Bosisio, F. M. & de Zio, Daniela, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3, 15 p., e006389.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy

    Johansen, A. Z., Novitski, Sif Ingibergsdóttir, Hjaltelin, Jessica Xin, Theile, S., Boisen, M. K., Brunak, Søren, Madsen, Daniel Hargbøl, Nielsen, Dorte Lisbet & Chen, I. M., 2023, In: Frontiers in Immunology. 14, 10 p., 1228907.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 22311148